Roku (NASDAQ:ROKU | ROKU Price Prediction) is the streaming name everyone wants to talk about after a 64.41% EPS beat and a 79.82% one-year run. But here’s what you should actually be watching. Roku ...

Iovance focuses on developing tumor-infiltrating lymphocytes (TILs) for cancer treatment. The company has reached the commercialization stage, with melanoma treatment Amtagvi as its flagship drug.

At current prices, CVS Health has a forward dividend yield of around 2.9%. That is considerably higher than UnitedHealth's ...

Bank of Montreal (TSX:BMO) looks like a timely dividend buy for investors. It’s a good time to be heavy in the U.S. tech names, but as the valuations rise and AI enthusiasm takes things to the next ...

Understand the fundamentals of growth investing to profit from high-growth stocks, along with valuable strategies, figures, ...

Nebius Group N.V. revenue surged 684%, gross margins hit 74%, and the Bloom deal solves for power. Learn more about NBIS ...

With rock-bottom fees and minimal turnover, this exchange-traded fund consistently outpaces most large-growth peers over the ...

Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Sources: FactSet, Dow Jones Stock Movers: Gainers, ...

Hydro One (TSX:H) stock looks like a great deal, even if shares are frothier than a year ago. For Canadian investors looking to play things a bit more defensively as the TSX Index, S&P 500, and Nasdaq ...

Key Points Interested in Redwire Corporation? Here are five stocks we like better. Luke Lango of InvestorPlace argues that ...

This week is all about Wednesday. That’s when the grand finale of earnings season will take place. Of course, that’s when NVIDIA Corporation (NVDA) will announce its first-quarter ...